Health Catalyst, Inc. (HCAT) Institutional Ownership

Ownership Summary

Health Catalyst, Inc. (NASDAQ:HCAT) has 131 institutional investors that have filed 13F reports for the period ending December 2025.

• Collectively, these holders controlled 78.2% of Health Catalyst's outstanding shares in December 2025, up from 78.1% in September 2025.
• They increased total shares held in Health Catalyst by 4.97% from last quarter, and the number of investors in HCAT decreased 22.02% annually.
• Of these 131 funds, 59 grew their exposure to Health Catalyst, 45 cut back, and 27 maintained positions.
• Combined, these investors held 55.03Mn shares in HCAT for December 2025, up by 2.6Mn shares quarter on quarter, and up 1.41Mn shares year over year.
• First Light Asset Management, LLC is the top holder of Health Catalyst as of December 31, 2025, with 12.88Mn shares representing 18.3% of outstanding stock.
• The most significant purchases of HCAT for the quarter ending December 2025 came from VANGUARD CAPITAL MANAGEMENT LLC (2.89Mn), CDC Financial, Inc. (2.31Mn), Palogic Value Management, L.P. (1.63Mn), Caption Management, LLC (771.89K), VANGUARD PORTFOLIO MANAGEMENT LLC (531.01K).
• The largest sales of HCAT for the quarter ending December 2025 came from ACADIAN ASSET MANAGEMENT LLC (819.52K), KENNEDY CAPITAL MANAGEMENT LLC (455.01K), DIMENSIONAL FUND ADVISORS LP (406.66K), JANE STREET GROUP, LLC (269.48K), Goldman Sachs Group Inc (246.43K).
• Per Business Quant data, the top 10 holders of Health Catalyst for the quarter ending December 2025 are First Light Asset Management, LLC (12.88Mn), CDC Financial, Inc. (6.31Mn), BlackRock, Inc. (5.14Mn), Whetstone Capital Advisors, LLC (4.27Mn), Palogic Value Management, L.P. (2.9Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.89Mn), Impax Asset Management Group plc (2.75Mn), Nepsis Inc. (1.88Mn), GEODE CAPITAL MANAGEMENT, LLC (1.5Mn), State Street Corp (1.32Mn).